Keywords: mca, rejects, reintroduction, troglitazone, ukmca, uk, medicines

MCA rejects reintroduction of troglitazone in the UKMCA rejects

Article | 29 March 1999

The UK Medicines Control Agency has rejected an application by GlaxoWellcome to reintroduce Romozin (troglitazone) for the treatment of type 2 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Sankyo

Lilly

Go to company listing

Related Drugs

Rezulin

Troglitazone

Go to drug listing